The biosynthesis of cytochrome P450 by rough endoplasmic reticulum in vitro A significant proportion of newly-biosynthesised cytochrome P450 is resistant to proteolytic digestion in intact vesicles by Craft, John A. et al.
Volume 98, number 2 FEBS LETTERS February 1979 
THE BIOSYNTHESIS OF CYTOCHROME P450 BY ROUGH ENDOPLASMIC 
RETICULUM IN VITRO 
A significant proportion of newly-biosynthesised cytochrome P450 is resistant to 
proteolytic digestion in intact vesicles 
John A. CRAFT, Michael B. COOPER, Margaret R. ESTALL and Brian R. RABIN 
Department of Biochemistry, University College London, Gower Street, London WCIE 6BT, England 
Received 3 November 1978 
1. Introduction 
Membrane proteins synthesised on polysomes of 
the rough endoplasmic reticulum are thought to be 
directly inserted into the membrane at the site of 
synthesis [l-6]. However, we have recently demon- 
strated that a part of the newly-biosynthesised cyto- 
chrome P4.50, a major membrane protein, can be 
found inside vesicles derived from the rough 
endoplasmic reticulum after protein synthesis in vitro 
[7,8]. Newly-biosynthesised cytochrome P450 has 
also been located inside vesciles derived from rough 
and smooth endoplasmic reticulum after incorpora- 
tion of radiolabelled amino acids in situ by perfusion 
of the liver [8]. In these studies intravesicular content 
is defined as the material released from reticular frac- 
tions by treatment with a low concentration of 
deoxycholate (0.05% w/v). Under the experimental 
conditions employed in these studies this level of 
detergent does not solubilise any of the spectrally- 
detectable cytochrome P450 [7-91. However, the 
possibility cannot be entirely eliminated that the 
newly-biosynthesised intravesicular cytochrome P450 
is a minor component which becomes highly radio- 
labelled during protein synthesis and is released from 
the membrane by low concentrations of deoxycholate. 
Intact microsomal vesicles are impermeable to 
macromolecules and thus treatment with proteases 
affects only those susceptible bonds which are present 
in proteins exposed on the outer membrane surface 
[lo]. Treatment of vesicles with deoxycholate (0.05% 
EIsevierlNorth-Holland Biomedical Press 
w/v) removes the permeability barrier and permits 
macromolecules to penetrate inside where they may 
interact with components in the luminal space and on 
the inner membrane surface [9,11,12]. In this study 
we show that a substantial proportion of the newly- 
biosynthesised, cytochrome P450, released by deoxy- 
cholate, is resistant to tryptic digestion of intact 
vesicles and therefore probably derives from the 
intravesicular compartment. 
2. Methods 
The rats used in these experiments were kept and 
treated with phenobarbital as in [7]. Rough endoplas- 
mic reticulum was prepared from the livers of these 
animals [13]. 
Cytochrome P450 was purified from the livers of 
phenobarbital-treated rats [8] and used to raise anti- 
bodies in New Zealand white rabbits [7,8]. The anti- 
bodies obtained are specific for cytochrome P450 as 
judged by Ouchterlony analysis, ability to precipitate 
spectrally-detectable cytochrome P450 from solubil- 
ised membrane and electrophoretic analysis of 
immunoprecipitates [7,8]. Radiolabelled polypeptides 
immunoprecipitated from subreticular fractions after 
protein synthesisin vitro have the same electrophoretic 
mobility as the cytochrome P450 used as antigen to 
prepare the antibodies [8 1. 
Protein synthesis in vitro was carried out as in [7] 
but using “r(Xabelled ammo acid hydrolysate 
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(56 mCi/matom) 4 &i/ml. Incubations were supple- 
mented with a non-radioactive mixture of those 
amino acids not present in the hydrolysate. 
After protein synthesis in vitro the particulate 
fraction was collected by centrifugation at 105 000 X g 
for 1 h at 4°C. The resultant pellet was resuspended 
to 2.6 mg membrane protein/ml in sodium pyrophos- 
phate (0.1 M)/EDTA (10 mM) solution adjusted to 
pH 7.5 with HCl. The protein concentration given 
here and later is based on the initial quantity of mem- 
brane used. After 30 min incubation at 0°C the mem- 
brane was recovered by centrifugation as before. The 
membrane pellet was resuspended to 1.8 mg protein/ 
ml in a solution containing Tris-HCI (50 mM, pH 7 S), 
KC1 (50 mM) and MgCl? (5 mM) (solution A). Aliquots 
of the resuspended membrane were either incubated 
without further additions (control treatment), or 
incubated with 50 pg trypsin/mg microsomal protein 
(trypsin treatment) or incubated with trypsin (50 pg/ 
mg microsomal protein) followed by deoxycholate to 
give final cont. 0.05%, w/v (trypsin and deoxycholate 
treatment). The tubes were incubated for 30 min at 
30°C and proteolysis terminated by the addition of a 
soyabean trypsin inhibitor (2 pg/pg trypsin) followed 
by transfer to a bath at 0°C. The particulate fraction 
was recovered by centrifugation as above. Aliquots of 
the resultant supernatants (S3) were retained for 
determination of radioactivity incorporated into 
material precipitated by trichloracetic acid. The partic- 
ulate fractions were resuspended to 1.8 mg mem- 
brane protein/ml in solution A. Soyabean trypsin 
inhibitor was added as before. Deoxycholate was 
added to 0.05% w/v and the membranes incubated 
for 30 min at 0°C. Particulate fractions (P4) were 
recovered by centrifugation as before. Aliquots of the 
resultant supernatants (S4) were used for the deter- 
mination of incorporated radioactivity either by 
immunoprecipitation or precipitation with trichloro- 
acetic acid. The residual membrane pellets (P4) were 
resuspended to 10 mg protein/ml in a solution con- 
taining sucrose (0.25 M), glycerol (20%, w/v) EDTA 
(1 mM) and sodium phosphate (100 mM, pH 7.7) 
(solution B). An aliquot of the resuspended mem- 
branes was used for the determination of incorporated 
radioactivity in material precipitated by trichloracetic 
acid. Where immunpprecipitation was required an 
aliquot of the resuspended membranes was solubilised 
by the addition of the appropriate volumes of a solu- 
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tion of sodium cholate dissolved in solution B (1 O%, 
w/v) to give final cont. 3 mg/mg membrane protein. 
The mixture was incubated for 30 min at 0°C and 
non-solubilised material removed by centrifugation 
as above. 
The determination of incorporated radioactivity in 
material precipitated by trichloroacetic acid and in 
immunoprecipitates have been detailed in [7]. Other 
methods were as in [7]. 
3. Results and discussion 
The radiolabelled amino acids incorporated in vitro 
into polypeptides in rough endoplasmic reticulum 
partition into various reticular subfractions. Newly- 
biosynthesised cytochrome P450 can be detected and 
quantified in these subfractions. Table 1 shows the 
effect of trypsin treatment on the distribution of 
radioactive polypeptides incorporated into subfrac- 
tions of rough endoplasmic reticulum. In these expe- 
riments rough endoplasmic reticulum was incubated 
in a protein synthesis system in the presence of 14C- 
labelled amino acids derived from a protein hydro- 
lysate. Polysomes were removed by treatment with 
pyrophosphate/EDTA prior to treatment with trypsin 
either in the presence or absence of deoxycholate. 
Trypsin treatment in the absence of deoxycholate 
resulted in the loss of > 50% of the incorporated 
radioactivity compared to untreated membrane. The 
loss in radioactivity is largely from the membrane 
(P4) although a small but significant loss from the 
vesicle content (S4) is observed probably due to 
breakage of some vesicles under the conditions of 
trypsin treatment. Other reports have also detailed 
a partial susceptibility of vesicle content to tryptic 
digestion [ 141. The protective effect of membrane 
vesicles on vesicle content can clearly be seen when 
the data is exatnined for trypsin treatment in the 
presence of deoxycholate. Under these conditions 
> 80% of incorporated radioactivity is lost, the radio- 
activity being greatly reduced in each subfraction. 
Thus -40% of radioactivity present in vesicles after 
in vitro protein synthesis is resistant to trypsin diges- 
tion either in the vesicular space or on the luminal mem- 
brane surface. Only a small portion of the incorporated 
radioactivity is resistant to digestion if there is access 
to both sides of the membrane. It cannot be deter- 
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Table 1 
Susceptibility of newly-biosynthesised proteins precipitated by trichloroacetic 
acid to trypsin digestion in the presence and absence of deoxycholate 
Reticular 
subfraction 
% of radioactivity precipitated by trichloroacetic acid 
Control Trypsin Trypsin and deoxycholate 
s3 4+1 4*1 6*2 
s4 32 F 2 20* 2 3+2 
P4 58 f 3 21 r 1 8il 
Total recovered 93 + 3 44 i: 3 18 r4 
Protein synthesis in vitro was carried out for 1 h in the presence of “‘C-1abelled 
amino acids. Membrane-bound polysomes were removed by treatment with EDTA/ 
pyrophosphate as described. The membrane thus obtained was resuspended in 
solution A and either untreated (control column) treated with trypsin in the 
absence (trypsin column) or presence (trypsin and deoxycholate) of 0.05% deoxy 
cholate as in section 2. Trypsin digestion was terminated with soyabean trypsin 
inhibitor and membranes recovered by ~entrifugation. Radioactivity precipitated 
by trichloroacetic acid was determined in the resulting supernatants (53). The 
membranes were resuspended in solution A and treated with deoxycholate (final 
corm. 0.05% w/v). The residual membrane (P4) was recovered by centrifugation 
and trichloroacetic acid pracipitable radioactivity determined in this fraction and 
the corresponding supernatant (S4). The results are expressed as the % of radio- 
activity recovered in each subfraction based on the amount of radioactivity in the 
starting control stripped membrane which ranged from 23 000-42 000 cpm/mg 
protein 
Table 2 
Effect of trygsin treatment of rough endoplasmic reticulum after protein synthesis in vitro: Recovery of immunoprecipitable 
radioactivity in reticular subfractions 
Reticular 
subfraction 
% of immunoprecipitable radioactivity in subfraction 
- 
Control treatment Trypsin treatment 
Antibody to 
cyt. P4.50 
Antibody to 
serum proteins 
Antibody to 
cyt. P450 
Antibody to 
serum proteins 
S4 
P4 
Total 
20 k 2 78t 1 12 + 1 51+3 
(22 f 5) (38 f 2) (19 f 2) (40 * 3) 
81 f 1 21 * 1 24 f 2 23 * 1 
(62 f 7) (12) (48 f 4) (16) 
100 100 36 74 
Protein synthesis in vitro was carried out in the presence of ‘4C-labelled amino acids. Membrane-bound polysomes were removed 
by treatment with EDTA/pyrophosphate and the resulting membrane resuspended in buffer A. This membrane was incubated in 
the absence (control) or presence of trypsin. Membrane was recovered by centrifugation and used to obtain the fraction released 
by deoxycholate (S4) and the residual membrane fraction (P4): (See section 2 and the legend to fig-l.) Aliquots of each frac- 
tion were subjected to immunoprecipitation as in section 2 using an antibody to cytochrome P4.50 or to rat serum proteins. The 
data show the % of immunoprecipitable radioactivity in each subfraction compared to the total recovered (S4 + P4) in the con- 
trol membrane. Tbis ranged from 4300-8900 cpm/mg protein using antibody to cytochrome P450 and 5000-7200 cpm/mg 
protein using antibody to serum proteins. Also included, in parentheses, is the % of immunoprecipitable radioactivity compared 
to the trichloroacetic acid precipitable radioactivity found in each subfraction 
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mined whether those membrane proteins resistant to 
digestion in the presence of deoxycholate are inherently 
resistant to the action of trypsin or whether they are 
buried in the membrane and are thus inaccessible. 
The nature of the radiolabelIed proteins present in 
the reticular subfractions after trypsin treatment has 
been investigated by quantitative immunoprecipita- 
Lion. The results are shown in table 2 which compares 
the immunoprecipitab~e radioactivity found in each 
subfraction compared to the total immunoprecipitab~e 
radioactivity recovered in the control membrane. Fol- 
lowing trypsin treatment, a significant proportion of 
the radioactivity found in the fraction released by 
deoxycholate is cytochrome P450. The amount of 
iil~lnunoprecipitab~e radioactivity attributable to 
cyt~~chrome P450 recovered in this subfraction after 
trypsin treatment is reduced compared to control 
membrane. This is consistent with loss due to vesicular 
damage since the amount of radioactivity precipitated 
by antibody to serum proteins present in the vesicle 
content is also reduced. The fractional loss is identical 
within the experinlental errors for serum proteins and 
cytochrome P450 (table 2). When the radioactivity 
immunoprecipitated from vesicle content by both 
antibody types is compared to the corresponding 
trichloroacetic acid-precipitable radioactivity the 
results are again identical for control and trypsin- 
treated membrane {table 2, figures in parentheses). 
Following trypsin treatment the amount of radio- 
activity which is present in the residual membrane 
fraction and which is precipitated by antibody to 
cytochrome P450 is greatly reduced. When the vesicle 
content was released in the presence of trypsin it con- 
tained <O.l% of the radioactivity immunoprecipitable 
by antibody to cytochrome P450 compared to the 
control treatment. The residual membrane also con- 
tained insignificant amounts of immunoprecipitable 
radioactivity after a combined treatment with deoxy- 
cholate and trypsin. 
Cytochrome P450 exists in multiple forms 
characterised by different spectral properties [ 15,161, 
different catalytic specificities [ 16,171, and by dif- 
ferent molecular weights [ 16,171. Topographical 
analysis of reticular membranes [9] has indicated that 
spectr~ly-detectable cytochrome P450 is distributed 
on both faces of the membrane bilayer as well as in 
the membrane core. This complex distribution is 
unusual for membrane proteins which are usually 
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specifically and asymmetrically distributed in the 
transverse plane of the membrane [9,18,19]. It may 
well be that individual variants of cytochrome P450 
are also distributed specifically and asyn~metricaIly 
across the membrane. The results of this study are 
highly relevant to this possibility since the topological 
variants of the cytochrome are probably synthesised 
by different routes. Thus the major part of the radio- 
activity incorporated into membrane-associated cyto- 
chrome P4.50 is accessible to trypsin. This may repre- 
sent a topological variant inserted directly into the 
membrane, since the N-terminal amino acid sequence 
of one electrophoretic variant of cytochrome P450 
has been shown to be homologous to the signal 
sequence of various pancreatic preproproteins [20]. 
This form of the cytochrome may be anchored directly 
into the membrane in the course of biosynthesis via 
its non-polar ‘signal sequence’. Our data clearly show 
that one or more variants of the cytochrome are 
translocated across the membrane in the course of 
biosynthesis, like export proteins. It is reasonable 
to suggest hat these newly-biosynthesised intravesicular 
molecules eventually are inserted into the lutninal 
membrane surface after transport through other com- 
ponents of the endoplasmic reticulum [8]. The results 
indicate that the radioactivity in the vesicle content, 
inlm~oprec~pitable by antibody to cytochrome P450 
does not arise by detergent displacement from a site 
on the exterior membrane face. 
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